Scalper1 News
Shares of Teva Pharmaceutical Industries (TEVA) abruptly rebounded Friday afternoon on reports that the drugmaker is thinking seriously about bidding for Mylan. Anonymous sources said Teva may or may not make an offer but is evaluating the idea and has approached advisers on the subject, Bloomberg reported. Most of Wall Street has been assuming that Teva was thinking about this at least since March 11, when rumors first emerged that Mylan (MYL) Scalper1 News
Scalper1 News